glp-1-directed nmda receptor antagonism for obesity treatment The Unstoppable Rise of GLP-1 Agonists: Revolutionising Diabetes and Metabolic Flux Adaptations During GLP-1

Semaglutide also inhibits the livers production of glucose, preventing excessive sugar from entering the bloodstream

Although the mechanism of action is not fully elucidated, the drug is thought to activate pathways in the brain that are involved in sexual responses

Donald Greig As we move further into the 21st century, medications like Ozempic, a GLP-1 agonist originally developed for diabetes management, are reshaping various aspects of daily life beyond their intended medical applications

Chest 119:394401

This review advances the central thesis that many peptidereceptor systems remain underexplored not because their biology is unsound, but because they were evaluated using outdated translational frameworks